Literature DB >> 20661185

Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury.

Florian Simon1, Angelika Scheuerle, Michael Gröger, Bettina Stahl, Ulrich Wachter, Josef Vogt, Günter Speit, Balázs Hauser, Peter Möller, Enrico Calzia, Csaba Szabó, Hubert Schelzig, Michael Georgieff, Peter Radermacher, Florian Wagner.   

Abstract

In rodents, inhaled H2S and injection of H2S donors protected against kidney ischemia/reperfusion (I/R) injury. During porcine aortic occlusion, the H2S donor Na2S (sulfide) reduced energy expenditure and decreased the noradrenaline requirements needed to maintain hemodynamic targets during early reperfusion. Therefore, we tested the hypothesis whether sulfide pretreatment may also ameliorate organ function in porcine aortic occlusion-induced kidney I/R injury. Anesthetized, ventilated, and instrumented pigs randomly received either sulfide or vehicle and underwent 90 min of kidney ischemia using intraaortic balloon-occlusion, and 8 h of reperfusion. During reperfusion, noradrenaline was titrated to maintain blood pressure at baseline levels. Sulfide attenuated the fall in creatinine clearance and the rise in creatinine blood levels, whereas renal blood flow and fractional Na+ excretion were comparable. Sulfide also lowered the blood IL-6, IL-1β, and nitrite + nitrate concentrations, which coincided with reduced kidney oxidative DNA base damage and iNOS expression, and attenuated glomerular histological injury as assessed by the incidence of glomerular tubularization. While expression of heme oxygenase 1 and cleaved caspase 3 did not differ, sulfide reduced the expression Bcl-xL and increased the activation of nuclear transcription factor κB. During porcine aortic occlusion-induced kidney I/R injury, sulfide pretreatment attenuated tissue injury and organ dysfunction as a result of reduced inflammation and oxidative and nitrosative stress. The higher nuclear transcription factor κB activation was probably due to the drop in temperature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20661185     DOI: 10.1097/SHK.0b013e3181f0dc91

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  23 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  H2S during circulatory shock: some unresolved questions.

Authors:  Oscar McCook; Peter Radermacher; Chiara Volani; Pierre Asfar; Anita Ignatius; Julia Kemmler; Peter Möller; Csaba Szabó; Matthew Whiteman; Mark E Wood; Rui Wang; Michael Georgieff; Ulrich Wachter
Journal:  Nitric Oxide       Date:  2014-03-18       Impact factor: 4.427

3.  Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury.

Authors:  Šárka Matějková; Angelika Scheuerle; Florian Wagner; Oscar McCook; José Matallo; Michael Gröger; Andrea Seifritz; Bettina Stahl; Brigitta Vcelar; Enrico Calzia; Michael Georgieff; Peter Möller; Hubert Schelzig; Peter Radermacher; Florian Simon
Journal:  Intensive Care Med       Date:  2013-01-05       Impact factor: 17.440

4.  Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury.

Authors:  Florian Simon; Angelika Scheuerle; Michael Gröger; Brigitta Vcelar; Oscar McCook; Peter Möller; Michael Georgieff; Enrico Calzia; Peter Radermacher; Hubert Schelzig
Journal:  Intensive Care Med       Date:  2011-07-16       Impact factor: 17.440

Review 5.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

6.  AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.

Authors:  Akbar Ahmad; Gabor Olah; Bartosz Szczesny; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

7.  Of mice and men (and sheep, swine etc.): the intriguing hemodynamic and metabolic effects of hydrogen sulfide (H2S).

Authors:  Katja Wagner; Michael Georgieff; Pierre Asfar; Enrico Calzia; Markus W Knöferl; Peter Radermacher
Journal:  Crit Care       Date:  2011-04-04       Impact factor: 9.097

8.  Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?

Authors:  Andrey V Kozlov; Soheyl Bahrami; Enrico Calzia; Peter Dungel; Lars Gille; Andrey V Kuznetsov; Jakob Troppmair
Journal:  Ann Intensive Care       Date:  2011-09-26       Impact factor: 6.925

9.  Effect of Nigella sativa on ischemia-reperfusion induced rat kidney damage.

Authors:  Shahrzad Havakhah; Hamid R Sadeghnia; Mosa-Al-Reza Hajzadeh; Nama Mohammadian Roshan; Somayeh Shafiee; Hossein Hosseinzadeh; Narges Mohareri; Abolfazl Khajavi Rad
Journal:  Iran J Basic Med Sci       Date:  2014-12       Impact factor: 2.699

Review 10.  Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.

Authors:  Eelke M Bos; Harry van Goor; Jaap A Joles; Matthew Whiteman; Henri G D Leuvenink
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.